TITLE: The SQuID Protocol: Subcutaneous Insulin in Diabetic Ketoacidosis

 

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

•Review the data on efficacy of insulin for treatment of DKA.

•Recognize potential operational improvements a SQ protocol might offer.

•Examine preliminary data on patient and provider satisfaction with a SQ insulin protocol and on potential targets for prevention of DKA.

 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.